What factors affect a sufficient dose of methylphenidate?

Methylfenidate HCI, also known as Ritalin & Reg, Concerta & Reg, Daytrana & Reg and metadate, is most often prescribed for attention disorder, although it is sometimes also used as an additional treatment for narcolepsy and depression. The slight stimulant of the central nervous system, methylphenidate is available at doses of 5 mg, 10 mg and 20 mg with immediate release. The drug is also available in enterically coated, permanent and widespread release tablets, which reduces the required frequency of the dose. Methylfenidate HCL patch has also been developed as a possibility of permanent release for children who are unable to swallow capsules. Reflections on dosing medicines containing methylphenidate depend on which of these forms are used, among other factors, such as age and treatment.

In children 6 years and older, chewing tablets should be used twice a day, preferably 30 minutes before meals. Initially, each dose should be between 2.5 and 5 mg, modified up the increments of 5 to 10 mg once a week untilMaximum 60 mg daily. Insomnia, one common side effect of the drug may be reduced by the last dose every day before 18:00. Initial doses for permanent release tablets should be equivalent to the overall dose of chewing tablets used within eight hours, and at the same time equivalent to the overall daily dose of methylphenidate. Extending tablets and permanent release will lose their properties with slow release when they are crushed or chewed.

In children using transdermally absorbed spots of methylphenidate, the initial dose of methylphenidate 10 mg in the nine hour period, if desired, is removed earlier. The dose can be increased to 15 mg after the first week, 20 mg after the second week and 30 mg after the third week until sufficient dose of methylphenidate is achieved. The patch should never be left for more than nine hours, as a psychoactive level will remain in the bloodstream for up to two hoursafter the patch is removed.

The

dose for the treatment of narcolepsy in adults is significantly higher than necessary for the treatment of attention disorder. The initial dose of chewing narcolepsy is 10 mg twice to three times a day, before eating to increase absorption. Maintenance doses can be carried out throughout the day as needed if the total daily dose does not exceed 60 mg per day. The widespread and lasting release tablets should be equal to the daily dose of methylphenidate of chewing tablets needed to treat narcolepsy.

While one of the more common off-tabel use of methylphenidate is as a complementary treatment of depression, for this purpose it has not received approval by the United States of food and drug administration (USFDA). Therefore, there are no official instructions for determining sufficient doses in the treatment of depression. Because methylphenidate is a stimulant, it can interact with other stimulating antidepressants such as bupropion, which requires the dose to be reduced.